Nanoparticles for cancer therapy: current progress and challenges
S Gavas, S Quazi, TM Karpiński - Nanoscale research letters, 2021 - Springer
Cancer is one of the leading causes of death and morbidity with a complex pathophysiology.
Traditional cancer therapies include chemotherapy, radiation therapy, targeted therapy, and …
Traditional cancer therapies include chemotherapy, radiation therapy, targeted therapy, and …
Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance
Y Yao, Y Zhou, L Liu, Y Xu, Q Chen, Y Wang… - Frontiers in molecular …, 2020 - frontiersin.org
Nanotechnology has been extensively studied and exploited for cancer treatment as
nanoparticles can play a significant role as a drug delivery system. Compared to …
nanoparticles can play a significant role as a drug delivery system. Compared to …
[HTML][HTML] Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
R Mattioli, A Ilari, B Colotti, L Mosca, F Fazi… - Molecular Aspects of …, 2023 - Elsevier
Anthracyclines have been important and effective treatments against a number of cancers
since their discovery. However, their use in therapy has been complicated by severe side …
since their discovery. However, their use in therapy has been complicated by severe side …
Polymeric micelles and cancer therapy: An ingenious multimodal tumor-targeted drug delivery system
SK Hari, A Gauba, N Shrivastava, RM Tripathi… - Drug Delivery and …, 2023 - Springer
Since the beginning of pharmaceutical research, drug delivery methods have been an
integral part of it. Polymeric micelles (PMs) have emerged as multifunctional nanoparticles in …
integral part of it. Polymeric micelles (PMs) have emerged as multifunctional nanoparticles in …
Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source
W Meng, C He, Y Hao, L Wang, L Li, G Zhu - Drug delivery, 2020 - Taylor & Francis
Extracellular vesicles (EVs), including exosomes, microvesicles, and apoptotic bodies, are
nanosized membrane vesicles derived from most cell types. Carrying diverse biomolecules …
nanosized membrane vesicles derived from most cell types. Carrying diverse biomolecules …
Mesoporous silica nanoparticles: A comprehensive review on synthesis and recent advances
Recent advancements in drug delivery technologies utilizing a variety of carriers have
resulted in a path-breaking revolution in the approach towards diagnosis and therapy alike …
resulted in a path-breaking revolution in the approach towards diagnosis and therapy alike …
Tumor microenvironment-responsive manganese-based nanomaterials for cancer treatment
H Fan, Z Guo - Coordination Chemistry Reviews, 2023 - Elsevier
Tumor microenvironment (TME), which characteristically displays hypoxia,
immunosuppression, reprogramming metabolism and mild acidity, has been considered as …
immunosuppression, reprogramming metabolism and mild acidity, has been considered as …
Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications
A Amiri, R Bagherifar, E Ansari Dezfouli… - Journal of Translational …, 2022 - Springer
Nanocarriers as drug/biomolecule delivery systems have been significantly developed
during recent decades. Given the stability, reasonable delivery efficiency, and safety of …
during recent decades. Given the stability, reasonable delivery efficiency, and safety of …
[HTML][HTML] Milk exosomes: Nature's abundant nanoplatform for theranostic applications
B Adriano, NM Cotto, N Chauhan, M Jaggi… - Bioactive materials, 2021 - Elsevier
Exosomes are a unique subpopulation of naturally occurring extracellular vesicles which are
smaller intracellular membrane nanoparticle vesicles. Exosomes have proven to be …
smaller intracellular membrane nanoparticle vesicles. Exosomes have proven to be …
The development and progress of nanomedicine for esophageal cancer diagnosis and treatment
X Li, L Chen, S Luan, J Zhou, X Xiao, Y Yang… - Seminars in cancer …, 2022 - Elsevier
Esophageal cancer (EC) is a common gastrointestinal malignancy with poor prognosis and
high mortality. Although combined therapeutic strategies have been developed, the 5-year …
high mortality. Although combined therapeutic strategies have been developed, the 5-year …